2015
DOI: 10.1111/myc.12427
|View full text |Cite
|
Sign up to set email alerts
|

The burden of serious human fungal infections in Brazil

Abstract: In Brazil, human fungal infections are prevalent, however, these conditions are not officially reportable diseases. To estimate the burden of serious fungal diseases in 1 year in Brazil, based on available data and published literature. Historical official data from fungal diseases were collected from Brazilian Unified Health System Informatics Department (DATASUS). For fungal diseases for which no official data were available, assumptions of frequencies were made by estimating based on published literature. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
74
1
16

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 125 publications
(97 citation statements)
references
References 20 publications
6
74
1
16
Order By: Relevance
“…There is probably some overlap between these groups as some patients with ABPA have severe asthma and all are sensitised to Aspergillus . Based on our data, the incidence and prevalence of respiratory fungal infections are one of the lowest in Latin American, contrasting with those reported for Brazil [25] and the Dominican Republic [26]. However, the lack of a prospective cohort study of ABPA or SAFS in Latin America or Chile, and no fungal sensitisation data apart from Alternaria spp., is a major limiting factor for our estimates.…”
Section: Resultscontrasting
confidence: 55%
“…There is probably some overlap between these groups as some patients with ABPA have severe asthma and all are sensitised to Aspergillus . Based on our data, the incidence and prevalence of respiratory fungal infections are one of the lowest in Latin American, contrasting with those reported for Brazil [25] and the Dominican Republic [26]. However, the lack of a prospective cohort study of ABPA or SAFS in Latin America or Chile, and no fungal sensitisation data apart from Alternaria spp., is a major limiting factor for our estimates.…”
Section: Resultscontrasting
confidence: 55%
“…It is based on a proposed methodology that has been widely used, including in neighboring countries [49,50,51]. This is a challenging task due to the lack of a mandatory surveillance system for the majority of fungal diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, in Brazil, there is no fungal infection in the list of officially reportable diseases, but the incidence of chronic pulmonary aspergillosis (CPA) was estimated to be as high as 6.2/100,000 inhabitants. However, fungal diseases are neglected by both the public and private health systems, and only a few cases are diagnosed and treated (29). The lack of CPA diagnosis and the consequent absence of treatment for these patients may help to explain the lack of resistant isolates in this study.…”
mentioning
confidence: 86%